ODT - Odonate Therapeutics - Stock Forecast

Pharmaceuticals - Sector

Healthcare - Industry

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $12.3. This is a potential upside of $12.3 (0%) from yesterday's end of day stock price of $0.

Odonate Therapeutics's activity chart (see below) currently has 9 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 90% with an average time for these price targets to be met of 161 days.

Most recent stock forecast was given by PAUL CHOI from GOLDMAN on 22-Mar-2021. First documented stock forecast 23-Oct-2018.

Best performing analysts who are covering ODT - Odonate Therapeutics:

Paul Choi Michael Yee

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

$4

$2.71 (210.08%)

$11

3 years 8 months 9 days ago
(22-Mar-2021)

4/5 (80%)

$0.04 (1.01%)

41

Buy

$40

$38.71 (3000.78%)

6 years 1 months 8 days ago
(23-Oct-2018)

1/1 (100%)

$24.56 (159.07%)

281

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ODT (Odonate Therapeutics) average time for price targets to be met?

On average it took 161 days on average for the stock forecasts to be realized with a an average price target met ratio 90

Which analyst has the current highest performing score on ODT (Odonate Therapeutics) with a proven track record?

PAUL CHOI

Which analyst has the current lower performing score on ODT (Odonate Therapeutics) with a proven track record?

MICHAEL YEE

Which analyst has the most public recommendations on ODT (Odonate Therapeutics)?

Paul Choi works at GOLDMAN SACHS and has 15 price targets and 9 ratings on ODT

Which analyst is the currently most bullish on ODT (Odonate Therapeutics)?

Michael Yee with highest potential upside - $38.71

Which analyst is the currently most reserved on ODT (Odonate Therapeutics)?

Paul Choi with lowest potential downside - $2.71

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?